Five pharma companies fine-tune OpenFold3 federated, lifting ligand-pose accuracy from 29% to 47%

AllThingsApx · x · 2026-09-15

Five pharmaceutical companies fine-tuned OpenFold3 in a federated setting on 20,000+ structures, raising correct ligand-pose predictions from 29% to 47%. A comment notes that if protein-structure prediction is still in the early fun part of its scaling law, structure-free discovery holds many low-hanging gains — the bottleneck is getting the right data.

Related event: Five Pharma Firms Federatively Fine-Tune OpenFold3 on 20,167 Private Structures(6 posts)→

Original post →

More from Research

Research channel →